JEMPERLI 500 mg concentrate for solution for infusion
GEICO 137-E
Phase 2 small_molecule active
Quick answer
JEMPERLI 500 mg concentrate for solution for infusion for MMRd/MSI-H stage II-III endometrial cancer is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- MMRd/MSI-H stage II-III endometrial cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active